We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 18

FSA review of insurance brokers’ anti-bribery and corruption controls
  • Norton Rose Fulbright LLP
  • United Kingdom
  • September 16 2009

The FSA has published some of the interim findings arising from its review of commercial insurance brokers' anti-bribery and corruption systems and controls


Compliance and the in-house lawyer: the pressure is on
  • Norton Rose Fulbright LLP
  • United Kingdom
  • April 23 2010

The traditional role of the in-house lawyer is changing


Bribery Act 2010
  • Norton Rose Fulbright LLP
  • United Kingdom
  • May 10 2010

The UK Bribery Bill received Royal Assent on 8 April 2010


First British whistleblower jailed over bribes to Greek officials
  • Norton Rose Fulbright LLP
  • United Kingdom
  • May 10 2010

Robert Dougall, a former vice-president of Leeds-based healthcare products company DePuy International, a subsidiary of Johnson & Johnson, became the first British whistleblower to be prosecuted by the SFO and imprisoned for involvement with corruption


FSA enforcement - powers and tools
  • Norton Rose Fulbright LLP
  • United Kingdom
  • May 10 2010

The FSA's new policy on assessment of enforcement penalties for corrupt and fraudulent acts is now in force and applies to conduct occurring after 6 March 2010


City of London Corporation’s report on avoiding corruption risks in City businesses
  • Norton Rose Fulbright LLP
  • United Kingdom
  • May 27 2010

Transparency International (TI) has published its report for the City of London Corporation focusing on corruption risks in financial services firms and the potential impact of the Bribery Act 2010 on the sector once it comes into force


Innospec Limited: first ‘global settlement’ between a cooperating company and the UK and US authorities
  • Norton Rose Fulbright LLP
  • United Kingdom, USA
  • March 26 2010

Innospec Limited, a subsidiary of Innospec Inc., a NASDAQ-listed company based in the US, and a manufacturer of a lead-based anti-knock fuel additive called Tetraethyl lead (‘TEL’), pleaded guilty in the UK in Southwark Crown Court on 18 March 2010 to charges brought under section 1 of the Criminal Law Act 1977 of conspiring to give or agree to give corrupt payments (contrary to section 1 of the Prevention of Corruption Act 1906) to Government Officials in Indonesia as inducements to secure, or as rewards for having secured, contracts with the Indonesian Government for the supply of TEL


Focus on insurance brokers: FSA final report on brokers’ anti-bribery and corruption controls
  • Norton Rose Fulbright LLP
  • United Kingdom
  • May 24 2010

The FSA has published its final report on anti-bribery and corruption in commercial insurance broking which concludes that the approach of broker firms to higher risk business with third parties has been too informal, with many brokers failing to apply a risk-based approach to anti-bribery and corruption in practice


UK Bribery Bill: ten things you should know
  • Norton Rose Fulbright LLP
  • United Kingdom
  • March 10 2010

The corporate community has become accustomed to the US authorities frequently investigating and prosecuting offences under the US Foreign Corrupt Practices Act (FCPA


Reforming bribery - the draft legislation
  • Norton Rose Fulbright LLP
  • United Kingdom
  • March 27 2009

In its report published on 20 November 2008, the Law Commission sought to tackle accusations that the UK is failing to deal with corporate corruption matters by proposing a long awaited radical overhaul of the bribery laws in England and Wales